ImmunoGen News

BioProcess International announces the online publication of the complete set of BPI Theater podcasts presented during the 2013 BIO International Convention, 2225 April in Chicago, IL.

Today, Wall Street Reports announced new research reports highlighting Alexion Pharmaceuticals, Inc. , BioMarin Pharmaceutical Inc. , Onyx Pharmaceuticals, Inc. , Questcor Pharmaceuticals, Inc. , and ImmunoGen, Inc. .

There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers.

ImmunoGen, Inc. is a biotechnology company. It develops anticancer therapeutics using its proprietary TAP technology.

Project Description: MarketLines' ImmunoGen, Inc. Mergers & Acquisitions , Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions , divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by ImmunoGen, Inc. since January 2007.

The number of bullish hedge fund bets stayed the same which is a slightly negative development in our experience At the moment, there are tons of gauges market participants can use to track the equity markets.

ImmunoGen, Inc. , a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload ADC technology, today announced the presentation of the first clinical data with the Company's IMGN853 product candidate.

ImmunoGen, Inc. develops targeted anticancer therapeutics. The Company's TAP technology uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's highly potent cancer cell-killing agents specifically to tumor cells.